Function and mechanism study of peptide TAG-23 in ischemia reperfusion injury

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000035118

Enrollment

Unknown

Registered

2020-08-01

Start date

2020-08-01

Completion date

Unknown

Last updated

2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial infarction

Interventions

healthy subjects vs myocardial infarction patients:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Clinical ECG ST-segment elevation or increased myocardial enzyme or acute myocardial infarction diagnosed by PCI. 2. Aged 18 - 75 years. 3. Within 12 hours of onset.

Exclusion criteria

Exclusion criteria: 1. Malignant tumor; 2. Severe liver and kidney disease; 3. Pregnant women.

Design outcomes

Primary

Measure	Time frame
Peptide TAG-23;	—

Countries

China

Contacts

Public ContactLingmei Qian

Shanghai Tongren Hospital

lmqian@njmu.edu.cn+86 13801593113

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026